Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 8, 2012, Pages

  Monticone, Silvia ^a   Hattangady, Namita G ^a   Nishimoto, Koshiro ^a   Mantero, Franco ^d   Rubin, Beatrice ^d   Cicala, Maria Verena ^d   Pezzani, Raffaele ^d   Auchus, Richard J ^b   Ghayee, Hans K ^e   Shibata, Hirotaka ^f   Kurihara, Isao ^f   Williams, Tracy A ^c   Giri, Judith G ^a   Bollag, Roni J ^a   Edwards, Michael A ^a   Isales, Carlos M ^a   Rainey, William E ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; POTASSIUM CHANNEL; PROTEIN KCNJ5; UNCLASSIFIED DRUG;

ADRENAL CORTEX CELL; ARTICLE; CONTROLLED STUDY; CYP11B2 GENE; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KCNJ5 GENE; NR4A2 GENE; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ZONA GLOMERULOSA;

ADENOMA; ADRENAL CORTEX; ADRENAL GLAND NEOPLASMS; ALDOSTERONE; CELL LINE, TUMOR; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GENE EXPRESSION PROFILING; HUMANS; MUTATION;

EID: 84864817326     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3132     Document Type: Article

References (18)

1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266-3281
2. Mulatero P 2008 A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J Clin Endocrinol Metab 93:2972-2974
3. Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP 2008 A novel form of human mendelian hypertension featuring nonglucocorticoid- remediable aldosteronism. J Clin Endocrinol Metab 93:3117-3123
4. Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP 2011 K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768-772
5. Auchus RJ, Michaelis C, Wians Jr FH, Dolmatch BL, Josephs SC, Trimmer CK, Anderson ME, Nwariaku FE 2009 Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism. Ann Surg 249:318-321
6. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A 2011 Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan Endocrine Society, 2009. Endocr J 58:711-721
7. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F 2006 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293-2300 (Pubitemid 44873058)
8. Wang T, Satoh F, Morimoto R, Nakamura Y, Sasano H, Auchus RJ, Edwards MA, Rainey WE 2011 Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands. Eur J Endocrinol 164:613-619
9. Wang T, Rainey WE 2012 Human adrenocortical carcinoma cell lines. Mol Cell Endocrinol 351:58-65
10. Azizan EA, Murthy M, Stowasser M, Gordon R, Kowalski B, Xu S, Brown MJ, O'Shaughnessy KM 2012 Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension 59:587-591
11. Boulkroun S, Beuschlein F, Rossi GP, Golib-Dzib JF, Fischer E, Amar L, Mulatero P, Samson-Couterie B, Hahner S, Quinkler M, Fallo F, Letizia C, Allolio B, Ceolotto G, Cicala MV, Lang K, Lefebvre H, Lenzini L, Maniero C, Monticone S, Perrocheau M, Pilon C, Plouin PF, Rayes N, Seccia TM, Veglio F, Williams TA, Zinnamosca L, Mantero F, Benecke A, Jeunemaitre X, Reincke M, ZennaroMC2012 Prevalence, clinical, and molecular correlates of KCNJ5mutations in primary aldosteronism. Hypertension 59:592-598
12. Taguchi R, Yamada M, Nakajima Y, Satoh T, Hashimoto K, Shibusawa N, Ozawa A, Okada S, Rokutanda N, Takata D, Koibuchi Y, Horiguchi J, Oyama T, Takeyoshi I, Mori M 2012 Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab 97:1311-1319
13. Condon JC, Pezzi V, Drummond BM, Yin S, Rainey WE 2002 Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology 143:3651-3657 (Pubitemid 34925742)
14. Nogueira EF, Rainey WE 2010 Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members. Endocrinology 151:1060-1070
15. Nogueira EF, Vargas CA, Otis M, Gallo-Payet N, Bollag WB, Rainey WE 2007 Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells. J Mol Endocrinol 39:365-374
16. Nogueira EF, Xing Y, Morris CA, Rainey WE 2009 Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis. J Mol Endocrinol 42:319-330
17. Pezzi V, Clyne CD, Ando S, Mathis JM, Rainey WE 1997 Ca(2+)-regulated expression of aldosterone synthase is mediated by calmodulin and calmodulin-dependent protein kinases. Endocrinology 138:835-838 (Pubitemid 27110940)
18. Huang L, Mivechi NF, Moskophidis D 2001 Insights into regulation and function of the major stress-induced hsp70 molecular chaper-one in vivo: analysis of mice with targeted gene disruption of the hsp70.1 or hsp70.3 gene. Mol Cell Biol 21:8575-8591 (Pubitemid 33108615)